original articlesgastrointestinal tumorsPhase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
gastrointestinal tumors
Under an Elsevier user license
open archive
Keywords
AMG 386
angiogenesis
angiopoietin
metastatic gastric cancer
peptibody
Tie2 receptor
Cited by (0)
Copyright © 2012 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.